Chimeric Flaviviruses: Novel Vaccines against Dengue Fever, Tick-borne Encephalitis, and Japanese Encephalitis
- 1 January 2003
- book chapter
- Published by Elsevier
- Vol. 61, 469-509
- https://doi.org/10.1016/s0065-3527(03)61013-4
Abstract
No abstract availableKeywords
This publication has 119 references indexed in Scilit:
- Chimeric Live, Attenuated Vaccine against Japanese Encephalitis (ChimeriVax‐JE): Phase 2 Clinical Trials for Safety and Immunogenicity, Effect of Vaccine Dose and Schedule, and Memory Response to Challenge with Inactivated Japanese Encephalitis AntigenThe Journal of Infectious Diseases, 2003
- Safety and immunogenicity of attenuated dengue virus vaccines (Aventis Pasteur) in human volunteersVaccine, 2001
- European Experience with the West Nile Virus Ecology and Epidemiology: Could It Be Relevant for the New World?Viral Immunology, 2000
- Japanese Encephalitis and Dengue VaccinesBiologicals, 1997
- Effectiveness of live-attenuated Japanese encephalitis vaccine (SA14-14-2): a case-control studyThe Lancet, 1996
- The envelope glycoprotein from tick-borne encephalitis virus at 2 Å resolutionNature, 1995
- A Live Attenuated Dengue-L Vaccine Candidate (45AZ5) Passaged In Primary Dog Kidney Cell Culture Is Attenuated And Immunogenic For HumansThe Journal of Infectious Diseases, 1994
- Antigenic Relationships between Flaviviruses as Determined by Cross-neutralization Tests with Polyclonal AntiseraJournal of General Virology, 1989
- Pathogenesis of Dengue: Challenges to Molecular BiologyScience, 1988
- A Virus Resembling Russian Spring–Summer Encephalitis Virus from an Ixodid Tick in MalayaNature, 1956